Business · 04/05/2023
FDA Announces Final Guidance on Quality Risk Management for Pharmaceuticals
The FDA has released a final guidance on quality risk management for pharmaceuticals, addressing issues with product availability, risk assessments, and decision-making, and replacing a draft guidance issued in 2022.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →